NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Status:	Completed
Conditions:	Neurology, Psychiatric, ADHD
Therapuetic Areas:	Neurology, Psychiatry / Psychology, Other
Healthy:	No
Age Range:	6 - 12
Updated:	4/21/2016
Start Date:	July 2012
End Date:	October 2012

A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom

The safety and efficacy of a chewable formulation of extended-release methylphenidate will
be studied in children with ADHD

Inclusion Criteria:

- Children aged 6 to 12 years with ADHD who require pharmacologic treatment for this
condition

Exclusion Criteria:

- Other serious illnesses or conditions that would put the patient at particular risk
for safety events or would interfere with treatment/assessment of ADHD

We found this trial at

sites

Florida Clinical Research Center, LLC

8043 Cooper Creek Boulevard Suite 107
Bradenton, Florida 34201

(941) 747-7900